Catalyst Pharmaceuticals (CPRX) Current Taxes (2023 - 2026)
Catalyst Pharmaceuticals (CPRX) reported Current Taxes of $19.6 million for Q1 2026, up 77.02% on a YoY basis from $11.1 million in Q1 2025, and up 1305.87% quarter-over-quarter from $1.4 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Current Taxes (2023 - 2026) Analysis & Trends
Catalyst Pharmaceuticals has reported Current Taxes for 4 years, with the latest figure at $19.6 million in Q1 2026.
- For the quarter ending Q1 2026, Current Taxes rose 77.02% year-over-year to $19.6 million; the trailing twelve-month figure through Mar 2026 stood at $19.6 million (up 77.02% YoY), and the FY2025 full-year result was $1.4 million, up 56.15% from the prior year.
- Current Taxes for Q1 2026 stood at $19.6 million, up from $1.4 million in the prior quarter.
- The five-year high for Current Taxes was $19.6 million in Q1 2026, with the low at $15000.0 in Q2 2024.
- Historically, Current Taxes has averaged $4.4 million across 4 years, with a median of $811500.0 in 2023.
- Annual changes were most pronounced in 2024 — Current Taxes grew 22.63% — and 2025, when it surged 2826.67%.
- Catalyst Pharmaceuticals' Current Taxes stood at $729000.0 in 2023, then gained by 22.63% to $894000.0 in 2024, then soared by 56.15% to $1.4 million in 2025, then jumped by 1305.87% to $19.6 million in 2026.
- The last three Current Taxes figures came in at $19.6 million (Q1 2026), $1.4 million (Q4 2025), and $710000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Catalyst Pharmaceuticals | 3.84 Bn | 3.08 Bn | 134.92 Mn | 19.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.63 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 710,000.00 |
| Jun 30, 2025 | 439,000.00 |
| Mar 31, 2025 | 11.09 Mn |
| Dec 31, 2024 | 894,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Dec 31, 2023 | 729,000.00 |